{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:06Z","timestamp":1787020086811,"version":"build-2736575974"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-025-03084-0","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:37:13Z","timestamp":1745667433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain"],"prefix":"10.1186","volume":"25","author":[{"given":"Mateusz","family":"Szczupak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Kobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cimoszko-Zauliczna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Krupa\u2011Nurcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ingielewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Wierzchowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"3","key":"3084_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.hgmx.2016.05.008","volume":"79","author":"J Alc\u00e1zar-Castro","year":"2016","unstructured":"Alc\u00e1zar-Castro J, Carrillo-Torres O, Gonz\u00e1lez-Navarro P. Role of buprenorphine in acute postoperative pain. Revista M\u00e9dica del Hospital General de M\u00e9xico. 2016;79(3):174\u201380.","journal-title":"Revista M\u00e9dica del Hospital General de M\u00e9xico"},{"key":"3084_CR2","doi-asserted-by":"publisher","unstructured":"Garland EL. Pain processing in the human nervous system: a selective review of nociceptive and biobehavioral pathways. Prim Care. 2012;39(3):561\u201371. https:\/\/doi.org\/10.1016\/j.pop.2012.06.013. Epub 2012 Jul 24. PMID: 22958566; PMCID: PMC3438523.","DOI":"10.1016\/j.pop.2012.06.013"},{"key":"3084_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11916-023-01114-5","volume":"27","author":"MY Jin","year":"2023","unstructured":"Jin MY, Everett ES, Abd-Elsayed A. Microbiological and Physiological Effects of Pain. Curr Pain Headache Rep. 2023;27:165\u201373. https:\/\/doi.org\/10.1007\/s11916-023-01114-5.","journal-title":"Curr Pain Headache Rep"},{"key":"3084_CR4","doi-asserted-by":"publisher","unstructured":"Eyob Asefa Bekele, Tseganesh Berhanu Tulu, Yonathan Abebe Bulto, Gebeyehu Tessema Azibte, Waltengus Birhanu. Prevalence and associated factors of acute postoperative pain in adult surgical patients: A prospective study. Surgery in Practice and Science. Volume 19, 2024, 100262, doi.org\/https:\/\/doi.org\/10.1016\/j.sipas.2024.100262.","DOI":"10.1016\/j.sipas.2024.100262"},{"issue":"3","key":"3084_CR5","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/MS9.0000000000001724.PMID:38463044;PMCID:PMC10923367","volume":"86","author":"S Timerga","year":"2024","unstructured":"Timerga S, Befkadu A, Seyoum F. Acute postoperative pain prevalence and intensity in the first 72 hour in Dessie Comprehensive Specialized Hospital, Ethiopia: a prospective single center observational study. Ann Med Surg (Lond). 2024;86(3):1322\u20138. https:\/\/doi.org\/10.1097\/MS9.0000000000001724.PMID:38463044;PMCID:PMC10923367.","journal-title":"Ann Med Surg (Lond)"},{"issue":"10","key":"3084_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.4103\/0019-5049.191686.PMID:27761037;PMCID:PMC5064698","volume":"60","author":"PK Singh","year":"2016","unstructured":"Singh PK, Saikia P, Lahakar M. Prevalence of acute post-operative pain in patients in adult age-group undergoing inpatient abdominal surgery and correlation of intensity of pain and satisfaction with analgesic management: A cross-sectional single institute-based study. Indian J Anaesth. 2016;60(10):737\u201343. https:\/\/doi.org\/10.4103\/0019-5049.191686.PMID:27761037;PMCID:PMC5064698.","journal-title":"Indian J Anaesth"},{"key":"3084_CR7","doi-asserted-by":"publisher","unstructured":"Gudin J, Fudin J. A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain. Pain Ther. 2020;9(1):41\u201354. https:\/\/doi.org\/10.1007\/s40122-019-00143-6. Epub 2020 Jan 28. PMID: 31994020; PMCID: PMC7203271.","DOI":"10.1007\/s40122-019-00143-6"},{"issue":"2","key":"3084_CR8","first-page":"62","volume":"3","author":"T Dzier\u017canowski","year":"2011","unstructured":"Dzier\u017canowski T, Cia\u0142kowska-Rysz A. Buprenorphine in the management of persistent pain \u2013 update review. Medycyna Paliatywna\/Palliative Medicine. 2011;3(2):62\u201375.","journal-title":"Medycyna Paliatywna\/Palliative Medicine"},{"key":"3084_CR9","doi-asserted-by":"publisher","unstructured":"Brennan TJ. Pathophysiology of postoperative pain. Pain. 2011;152(3 Suppl):S33-S40. https:\/\/doi.org\/10.1016\/j.pain.2010.11.005. Epub 2011 Jan 12. PMID: 21232860; PMCID: PMC3073562.","DOI":"10.1016\/j.pain.2010.11.005"},{"key":"3084_CR10","doi-asserted-by":"publisher","first-page":"1154597","DOI":"10.3389\/fpain.2023.1154597","volume":"4","author":"AM Fuller","year":"2023","unstructured":"Fuller AM, Bharde S, Sikandar S. The mechanisms and management of persistent postsurgical pain. Front Pain Res. 2023;4:1154597. https:\/\/doi.org\/10.3389\/fpain.2023.1154597.","journal-title":"Front Pain Res"},{"issue":"2","key":"3084_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000000588.PMID:29392204;PMCID:PMC5770176","volume":"2","author":"EM Pogatzki-Zahn","year":"2017","unstructured":"Pogatzki-Zahn EM, Segelcke D, Schug SA. Postoperative pain-from mechanisms to treatment. Pain Rep. 2017;2(2): e588. https:\/\/doi.org\/10.1097\/PR9.0000000000000588.PMID:29392204;PMCID:PMC5770176.","journal-title":"Pain Rep"},{"issue":"4","key":"3084_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.phrs.2012.01.002","volume":"65","author":"AA Weinbroum","year":"2012","unstructured":"Weinbroum AA. Non-opioid IV adjuvants in the perioperative period: pharmacological and clinical aspects of ketamine and gabapentinoids. Pharmacol Res. 2012;65(4):411\u201329. https:\/\/doi.org\/10.1016\/j.phrs.2012.01.002. Epub 2012 Jan 30 PMID: 22311381.","journal-title":"Pharmacol Res"},{"issue":"9","key":"3084_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012.PMID:19712899;PMCID:PMC2750819","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895\u2013926. https:\/\/doi.org\/10.1016\/j.jpain.2009.06.012.PMID:19712899;PMCID:PMC2750819.","journal-title":"J Pain"},{"key":"3084_CR14","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.tins.2003.09.017","volume":"26","author":"R Ji","year":"2003","unstructured":"Ji R, Kohno T, Moore K, et al. La sensibilizaci\u00f3n central y LTP: hacer del dolor y la memoria comparten mecanismos similares? Trends Neurosci. 2003;26:696\u2013705.","journal-title":"Trends Neurosci"},{"issue":"1","key":"3084_CR15","first-page":"11","volume":"83","author":"N Vadivelu","year":"2010","unstructured":"Vadivelu N, Mitra S, Narayan D. Recent advances in postoperative pain management. Yale J Biol Med. 2010;83(1):11\u201325. PMID: 20351978; PMCID: PMC2844689.","journal-title":"Yale J Biol Med."},{"issue":"3","key":"3084_CR16","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.14602.PMID:28824867;PMCID:PMC5559703","volume":"7","author":"MS Meymandi","year":"2017","unstructured":"Meymandi MS, Keyhanfar F, Sepehri GR, Heravi G, Yazdanpanah O. The Contribution of NMDA Receptors in Antinociceptive Effect of Pregabalin: Comparison of Two Models of Pain Assessment. Anesth Pain Med. 2017;7(3): e14602. https:\/\/doi.org\/10.5812\/aapm.14602.PMID:28824867;PMCID:PMC5559703.","journal-title":"Anesth Pain Med"},{"issue":"6","key":"3084_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6.PMID:22020140;PMCID:PMC3698859","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115(6):1363\u201381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6.PMID:22020140;PMCID:PMC3698859.","journal-title":"Anesthesiology"},{"issue":"24","key":"3084_CR18","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.cell.2023.10.029.PMID:37995655;PMCID:PMC10710086","volume":"186","author":"T Che","year":"2023","unstructured":"Che T, Roth BL. Molecular basis of opioid receptor signaling. Cell. 2023;186(24):5203\u201319. https:\/\/doi.org\/10.1016\/j.cell.2023.10.029.PMID:37995655;PMCID:PMC10710086.","journal-title":"Cell"},{"key":"3084_CR19","unstructured":"https:\/\/www.nursingtimes.net\/pain-management\/understanding-the-effect-of-pain-and-how-the-human-body-responds-26-02-2018\/"},{"issue":"2","key":"3084_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000457.PMID:30531584;PMCID:PMC7442141","volume":"13","author":"MA Coe","year":"2019","unstructured":"Coe MA, Lofwall MR, Walsh SL. Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations. J Addict Med. 2019;13(2):93\u2013103. https:\/\/doi.org\/10.1097\/ADM.0000000000000457.PMID:30531584;PMCID:PMC7442141.","journal-title":"J Addict Med."},{"key":"3084_CR21","doi-asserted-by":"publisher","unstructured":"Walsh, S.L., Middleton, L.S. (2013). Buprenorphine Pharmacodynamics and Pharmacokinetics. In: Cruciani, R., Knotkova, H. (eds) Handbook of Methadone Prescribing and Buprenorphine Therapy. Springer, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4614-6974-2_12","DOI":"10.1007\/978-1-4614-6974-2_12"},{"issue":"3","key":"3084_CR22","first-page":"77","volume":"10","author":"M Kocot-K\u0119pska","year":"2016","unstructured":"Kocot-K\u0119pska M, Przeklasa-Muszy\u0144ska A, Dobrogowski J. Buprenorphine - opioid with unique properties. Medycyna Paliatywna w Praktyce. 2016;10(3):77\u201388.","journal-title":"Medycyna Paliatywna w Praktyce"},{"issue":"3","key":"3084_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5604\/01.3001.0009.5274","volume":"17","author":"M Widenka","year":"2016","unstructured":"Widenka M, Leppert W. Rola przezsk\u00f3rnej buprenorfiny w leczeniu b\u00f3lu przewlek\u0142ego u chorych w wieku podesz\u0142ym. B\u00d3L. 2016;17(3):53\u201363. https:\/\/doi.org\/10.5604\/01.3001.0009.5274.","journal-title":"B\u00d3L"},{"issue":"6","key":"3084_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/biom11060816.PMID:34072706;PMCID:PMC8230089","volume":"11","author":"R Infantino","year":"2021","unstructured":"Infantino R, Mattia C, Locarini P, Pastore AL, Maione S, Luongo L. Buprenorphine: Far Beyond the \u201cCeiling.\u201d Biomolecules. 2021;11(6):816. https:\/\/doi.org\/10.3390\/biom11060816.PMID:34072706;PMCID:PMC8230089.","journal-title":"Biomolecules"},{"issue":"18","key":"3084_CR25","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000.PMID:10995854;PMCID:PMC6772839","volume":"20","author":"TW Vanderah","year":"2000","unstructured":"Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, Zhang ET, Malan TP Jr, Ossipov MH, Lai J, Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci. 2000;20(18):7074\u20139. https:\/\/doi.org\/10.1523\/JNEUROSCI.20-18-07074.2000.PMID:10995854;PMCID:PMC6772839.","journal-title":"J Neurosci"},{"key":"3084_CR26","doi-asserted-by":"publisher","unstructured":"Falcon E, Maier K, Robinson SA, Hill-Smith TE, Lucki I. Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice. Psychopharmacology (Berl). 2015;232(5):907\u201315. https:\/\/doi.org\/10.1007\/s00213-014-3723-y. Epub 2014 Sep 3. PMID: 25178815; PMCID: PMC4326609.","DOI":"10.1007\/s00213-014-3723-y"},{"key":"3084_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/164_2020_432","volume":"271","author":"CA Browne","year":"2022","unstructured":"Browne CA, Wulf H, Lucki I. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder. Handb Exp Pharmacol. 2022;271:493\u2013524. https:\/\/doi.org\/10.1007\/164_2020_432. (PMID: 33580854).","journal-title":"Handb Exp Pharmacol"},{"key":"3084_CR28","unstructured":"Li W, Sun H, Chen H, Yang X, Xiao L, Liu R, Shao L, Qiu Z. Major Depressive Disorder and Kappa Opioid Receptor Antagonists. Transl Perioper Pain Med. 2016;1(2):4\u201316. PMID: 27213169; PMCID: PMC4871611."},{"key":"3084_CR29","doi-asserted-by":"publisher","unstructured":"Ding Z, Raffa RB. Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine. Br J Pharmacol. 2009;157(5):831\u201343. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00209.x. Epub 2009 Apr 30. PMID: 19422392; PMCID: PMC2721267.","DOI":"10.1111\/j.1476-5381.2009.00209.x"},{"key":"3084_CR30","unstructured":"https:\/\/podyplomie.pl\/chirurgia\/29227,opioidowe-leki-przeciwbolowe?page=4"},{"key":"3084_CR31","unstructured":"https:\/\/www.google.pl\/url?sa=t&source=web&rct=j&opi=89978449&url=https:\/\/rejestry.ezdrowie.gov.pl\/api\/rpl\/medicinal-products\/1194\/characteristic&ved=2ahUKEwjM3PrZjO6MAxWRSzABHYL4IhwQFnoECBkQAQ&usg=AOvVaw2d-Vi74P-EpyvzjK7usqfi"},{"key":"3084_CR32","doi-asserted-by":"publisher","unstructured":"Kharidia J, Howgate EM, Laffont CM, Liu Y, Young MA. Evaluation of Drug-Drug Interaction Liability for Buprenorphine Extended-Release Monthly Injection Administered by Subcutaneous Route. Clin Pharmacol Drug Dev. 2021;10(9):1064\u20131074. https:\/\/doi.org\/10.1002\/cpdd.934. Epub 2021 Mar 22. PMID: 33750027; PMCID: PMC8451859.","DOI":"10.1002\/cpdd.934"},{"key":"3084_CR33","unstructured":"Curtin LI, Grakowsky JA, Suarez M, Thompson AC, DiPirro JM, Martin LB, Kristal MB. Evaluation of buprenorphine in a postoperative pain model in rats. Comp Med. 2009;59(1):60\u201371. PMID: 19295055; PMCID: PMC2703135."},{"key":"3084_CR34","doi-asserted-by":"publisher","unstructured":"Induru RR, Davis MP. Buprenorphine for neuropathic pain--targeting hyperalgesia. Am J Hosp Palliat Care. 2009 Dec-2010;26(6):470\u20133. https:\/\/doi.org\/10.1177\/1049909109341868. Epub 2009 Aug 7. PMID: 19666890.","DOI":"10.1177\/1049909109341868"},{"key":"3084_CR35","doi-asserted-by":"publisher","unstructured":"Hans G. Buprenorphine--a review of its role in neuropathic pain. J Opioid Manag. 2007;3(4):195\u2013206. https:\/\/doi.org\/10.5055\/jom.2007.0005. PMID: 17957979.","DOI":"10.5055\/jom.2007.0005"},{"key":"3084_CR36","doi-asserted-by":"publisher","unstructured":"Wiffen PJ, Derry S, Moore R, Stannard C, Aldington D, Cole P, Knaggs R. Buprenorphine for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2015, Issue 9. Art. No.: CD011603. https:\/\/doi.org\/10.1002\/14651858.CD011603.pub2","DOI":"10.1002\/14651858.CD011603.pub2"},{"key":"3084_CR37","doi-asserted-by":"publisher","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8(4):287\u2013313. https:\/\/doi.org\/10.1111\/j.1533-2500.2008.00204.x. Epub 2008 May 23. PMID: 18503626.","DOI":"10.1111\/j.1533-2500.2008.00204.x"},{"issue":"8","key":"3084_CR38","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1185\/030079905X53315","volume":"21","author":"N Griessinger","year":"2005","unstructured":"Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice\u2013a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin. 2005;21(8):1147\u201356. https:\/\/doi.org\/10.1185\/030079905X53315. PMID: 16083522.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"3084_CR39","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1213\/01.ANE.0000145066.06538.20","volume":"100","author":"R Likar","year":"2005","unstructured":"Likar R, Sittl R. Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies. Anesth Analg. 2005;100(3):781\u20135. https:\/\/doi.org\/10.1213\/01.ANE.0000145066.06538.20. PMID: 15728068.","journal-title":"Anesth Analg"},{"issue":"2","key":"3084_CR40","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.4081\/ejtm.2019.8098.PMID:31354919;PMCID:PMC6615365","volume":"29","author":"SM Jamalian","year":"2019","unstructured":"Jamalian SM, Sotodeh M, Mohaghegh F. Comparison of sublingual buprenorphine and intravenous morphine in reducing bone metastases associated pain in cancer patients. Eur J Transl Myol. 2019;29(2):8098. https:\/\/doi.org\/10.4081\/ejtm.2019.8098.PMID:31354919;PMCID:PMC6615365.","journal-title":"Eur J Transl Myol"},{"issue":"4","key":"3084_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.annemergmed.2011.10.021","volume":"59","author":"M Jalili","year":"2012","unstructured":"Jalili M, Fathi M, Moradi-Lakeh M, Zehtabchi S. Sublingual buprenorphine in acute pain management: a double-blind randomized clinical trial. Ann Emerg Med. 2012;59(4):276\u201380. https:\/\/doi.org\/10.1016\/j.annemergmed.2011.10.021. (Epub 2011 Nov 23 PMID: 22115823).","journal-title":"Ann Emerg Med"},{"issue":"3","key":"3084_CR42","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1476-5381.2010.01180.x.PMID:21182491;PMCID:PMC3195916","volume":"164","author":"T Andresen","year":"2011","unstructured":"Andresen T, Staahl C, Oksche A, Mansikka H, Arendt-Nielsen L, Drewes AM. Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain. Br J Pharmacol. 2011;164(3):934\u201345. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01180.x.PMID:21182491;PMCID:PMC3195916.","journal-title":"Br J Pharmacol"},{"key":"3084_CR43","doi-asserted-by":"publisher","unstructured":"Guillory AN, Clayton RP, Prasai A, Jay JW, Wetzel M, El Ayadi A, Herndon DN, Finnerty CC. Buprenorphine-Sustained Release Alters Hemodynamic Parameters in a Rat Burn Model. J Surg Res. 2018;232:154\u2013159. https:\/\/doi.org\/10.1016\/j.jss.2018.03.016. Epub 2018 Jul 5. PMID: 30463712; PMCID: PMC6251494.","DOI":"10.1016\/j.jss.2018.03.016"},{"key":"3084_CR44","doi-asserted-by":"publisher","unstructured":"Corli O, Floriani I, Roberto A, Montanari M, Galli F, Greco MT, Caraceni A, Kaasa S, Dragani TA, Azzarello G, Luzzani M, Cavanna L, Bandieri E, Gamucci T, Lipari G, Di Gregorio R, Valenti D, Reale C, Pavesi L, Iorno V, Crispino C, Pacchioni M, Apolone G; CERP STUDY OF PAIN GROUP (List of collaborators). Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. Ann Oncol. 2016;27(6):1107\u20131115. https:\/\/doi.org\/10.1093\/annonc\/mdw097. Epub 2016 Mar 2. PMID: 26940689.","DOI":"10.1093\/annonc\/mdw097"},{"issue":"1","key":"3084_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40271-015-0151-y.PMID:26547914;PMCID:PMC4720699","volume":"9","author":"M Serpell","year":"2016","unstructured":"Serpell M, Tripathi S, Scherzinger S, Rojas-Farreras S, Oksche A, Wilson M. Assessment of Transdermal Buprenorphine Patches for the Treatment of Chronic Pain in a UK Observational Study. Patient. 2016;9(1):35\u201346. https:\/\/doi.org\/10.1007\/s40271-015-0151-y.PMID:26547914;PMCID:PMC4720699.","journal-title":"Patient"},{"issue":"7","key":"3084_CR46","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamainternmed.2016.1251","volume":"176","author":"C Abdel Shaheed","year":"2016","unstructured":"Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016;176(7):958\u201368. https:\/\/doi.org\/10.1001\/jamainternmed.2016.1251. (PMID: 27213267).","journal-title":"JAMA Intern Med"},{"issue":"1","key":"3084_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/s0149-2918(03)90019-1","volume":"25","author":"R Sittl","year":"2003","unstructured":"Sittl R, Griessinger N, Likar R. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial. Clin Ther. 2003;25(1):150\u201368. https:\/\/doi.org\/10.1016\/s0149-2918(03)90019-1. (PMID: 12637117).","journal-title":"Clin Ther"},{"issue":"1","key":"3084_CR48","doi-asserted-by":"publisher","first-page":"27241","DOI":"10.52965\/001c.27241.PMID:34746493;PMCID:PMC8567798","volume":"9","author":"S Dalal","year":"2021","unstructured":"Dalal S, Chitneni A, Berger AA, Orhurhu V, Dar B, Kramer B, Nguyen A, Pruit J, Halsted C, Kaye AD, Hasoon J. Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids. Health Psychol Res. 2021;9(1):27241. https:\/\/doi.org\/10.52965\/001c.27241.PMID:34746493;PMCID:PMC8567798.","journal-title":"Health Psychol Res"},{"key":"3084_CR49","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2147\/JMDH.S449748","volume":"17","author":"J Adler","year":"2024","unstructured":"Adler J, Mallick-Searle T, Garofoli M, Zimmerman A. Frontline Perspectives on Buprenorphine for the Management of Chronic Pain. J Multidiscip Healthc. 2024;17:1375\u201383. https:\/\/doi.org\/10.2147\/JMDH.S449748.","journal-title":"J Multidiscip Healthc"},{"issue":"Suppl 2","key":"3084_CR50","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2165\/1158409-S0-000000000-00000","volume":"30","author":"A Gatti","year":"2010","unstructured":"Gatti A, Dauri M, Leonardis F, Longo G, Marinangeli F, Mammucari M, Sabato AF. Transdermal buprenorphine in non-oncological moderate-to-severe chronic pain. Clin Drug Investig. 2010;30(Suppl 2):31\u20138. https:\/\/doi.org\/10.2165\/1158409-S0-000000000-00000. (PMID: 20670047).","journal-title":"Clin Drug Investig"},{"issue":"1","key":"3084_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/00325481.2014.992715","volume":"127","author":"A Yarlas","year":"2015","unstructured":"Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Pergolizzi JV Jr, Raffa R, Ripa SR. Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain. Postgrad Med. 2015;127(1):38\u201345. https:\/\/doi.org\/10.1080\/00325481.2014.992715. (Epub 2014 Dec 15 PMID: 25526229).","journal-title":"Postgrad Med"},{"issue":"6","key":"3084_CR52","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/ALN.0b013e3182557917","volume":"116","author":"A Leffler","year":"2012","unstructured":"Leffler A, Frank G, Kistner K, Niedermirtl F, Koppert W, Reeh PW, Nau C. Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial \u03bc-opioid receptor agonist buprenorphine. Anesthesiology. 2012;116(6):1335\u201346. https:\/\/doi.org\/10.1097\/ALN.0b013e3182557917. (PMID: 22504149).","journal-title":"Anesthesiology"},{"key":"3084_CR53","doi-asserted-by":"publisher","unstructured":"Singh AP, Kaur R, Gupta R, Kumari A. Intrathecal buprenorphine versus fentanyl as adjuvant to 0.75% ropivacaine in lower limb surgeries. J Anaesthesiol Clin Pharmacol. 2016;32(2):229\u201333. https:\/\/doi.org\/10.4103\/0970-9185.182107. PMID: 27275055; PMCID: PMC4874080.","DOI":"10.4103\/0970-9185.182107"},{"key":"3084_CR54","doi-asserted-by":"publisher","unstructured":"Patil S, Debata D, Doshi C, Vyas V, Sinha S. Effect of buprenorphine as an adjunct with plain local anesthetic solution in supraclavicular brachial plexus block on quality and duration of postoperative analgesia. J Anaesthesiol Clin Pharmacol. 2015;31(4):496\u2013500. https:\/\/doi.org\/10.4103\/0970-9185.169072. PMID: 26702207; PMCID: PMC4676239.","DOI":"10.4103\/0970-9185.169072"},{"issue":"12","key":"3084_CR55","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1097\/CCM.0000000000006031","volume":"51","author":"AE Patanwala","year":"2023","unstructured":"Patanwala AE, Moran B, Johnstone C, Koelzow H, Penm J. Effectiveness of Sublingual Buprenorphine for Pain Control in the ICU. Crit Care Med. 2023;51(12):1650\u20138. https:\/\/doi.org\/10.1097\/CCM.0000000000006031. (Epub 2023 Aug 29 PMID: 37642505).","journal-title":"Crit Care Med"},{"issue":"6","key":"3084_CR56","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.clinthera.2006.06.012","volume":"28","author":"R Likar","year":"2006","unstructured":"Likar R, Kayser H, Sittl R. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther. 2006;28(6):943\u201352. https:\/\/doi.org\/10.1016\/j.clinthera.2006.06.012. (PMID: 16860176).","journal-title":"Clin Ther"},{"issue":"4","key":"3084_CR57","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.clinthera.2005.04.007","volume":"27","author":"C Muriel","year":"2005","unstructured":"Muriel C, Failde I, Mic\u00f3 JA, Neira M, S\u00e1nchez-Magro I. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther. 2005;27(4):451\u201362. https:\/\/doi.org\/10.1016\/j.clinthera.2005.04.007. (PMID: 15922818).","journal-title":"Clin Ther"},{"key":"3084_CR58","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2147\/JPR.S85951","volume":"8","author":"I Khanna","year":"2015","unstructured":"Khanna I, Pillarisetti S. Buprenorphine \u2013 an attractive opioid with underutilized potential in treatment of chronic pain. J Pain Res. 2015;8:859\u201370. https:\/\/doi.org\/10.2147\/JPR.S85951.","journal-title":"J Pain Res"},{"key":"3084_CR59","doi-asserted-by":"publisher","unstructured":"Davis MP. Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain. J Support Oncol. 2012;10(6):209\u201319. https:\/\/doi.org\/10.1016\/j.suponc.2012.05.002. Epub 2012 Jul 17. PMID: 22809652.","DOI":"10.1016\/j.suponc.2012.05.002"},{"issue":"1","key":"3084_CR60","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/ALN.0b013e3181c38c25","volume":"112","author":"A Dahan","year":"2010","unstructured":"Dahan A, Aarts L, Smith TW. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression. Anesthesiology. 2010;112(1):226\u201338. https:\/\/doi.org\/10.1097\/ALN.0b013e3181c38c25. (PMID: 20010421).","journal-title":"Anesthesiology"},{"issue":"4","key":"3084_CR61","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1360-0443.2006.01731.x","volume":"102","author":"S Nielsen","year":"2007","unstructured":"Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment. Addiction. 2007;102(4):616\u201322. https:\/\/doi.org\/10.1111\/j.1360-0443.2006.01731.x. (Epub 2007 Feb 6 PMID: 17286641).","journal-title":"Addiction"},{"issue":"5","key":"3084_CR62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1093\/bja\/ael051","volume":"96","author":"A Dahan","year":"2006","unstructured":"Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96(5):627\u201332. https:\/\/doi.org\/10.1093\/bja\/ael051. (Epub 2006 Mar 17 PMID: 16547090).","journal-title":"Br J Anaesth"},{"issue":"3","key":"3084_CR63","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.taap.2005.08.002","volume":"212","author":"B M\u00e9garbane","year":"2006","unstructured":"M\u00e9garbane B, Marie N, Pirnay S, Borron SW, Gueye PN, Ris\u00e8de P, Monier C, Noble F, Baud FJ. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicol Appl Pharmacol. 2006;212(3):256\u201367. https:\/\/doi.org\/10.1016\/j.taap.2005.08.002. (Epub 2005 Sep 16 PMID: 16169027).","journal-title":"Toxicol Appl Pharmacol"},{"key":"3084_CR64","doi-asserted-by":"publisher","unstructured":"Yassen A, Olofsen E, Kan J, Dahan A, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats. Pharm Res. 2008 Jan;25(1):183\u201393. https:\/\/doi.org\/10.1007\/s11095-007-9440-z. Epub 2007 Oct 4. PMID: 17914664; PMCID: PMC2190336.","DOI":"10.1007\/s11095-007-9440-z"},{"key":"3084_CR65","doi-asserted-by":"publisher","unstructured":"McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010;19(1):4\u201316. https:\/\/doi.org\/10.1111\/j.1521-0391.2009.00005.x. PMID: 20132117; PMCID: PMC3334287.","DOI":"10.1111\/j.1521-0391.2009.00005.x"},{"issue":"3","key":"3084_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","volume":"13","author":"HG Kress","year":"2009","unstructured":"Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain. 2009;13(3):219\u201330. https:\/\/doi.org\/10.1016\/j.ejpain.2008.04.011. (Epub 2008 Jun 24 PMID: 18567516).","journal-title":"Eur J Pain"},{"key":"3084_CR67","first-page":"92","volume-title":"Buprenorphine \u2013 The Unique Opioid Analgesic","author":"EA Shipton","year":"2005","unstructured":"Shipton EA. Safety and tolerability of buprenorphine. In: Budd K, Raffa R, editors. Buprenorphine \u2013 The Unique Opioid Analgesic. Stuttgart: Thieme Verlag KG; 2005. p. 92\u2013101."},{"key":"3084_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2017.00001","volume":"4","author":"E Afghani","year":"2017","unstructured":"Afghani E, Lo SK, Covington PS, Cash BD, Pandol SJ. Sphincter of Oddi Function and Risk Factors for Dysfunction. Front Nutr. 2017;4:1. https:\/\/doi.org\/10.3389\/fnut.2017.00001.","journal-title":"Front Nutr"},{"issue":"5","key":"3084_CR69","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/01.jcp.0000178417.60426.60","volume":"25","author":"M Soyka","year":"2005","unstructured":"Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial. J Clin Psychopharmacol. 2005;25(5):490\u20133. https:\/\/doi.org\/10.1097\/01.jcp.0000178417.60426.60. (PMID: 16160628).","journal-title":"J Clin Psychopharmacol"},{"issue":"2\u20133","key":"3084_CR70","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2011.01.017","volume":"117","author":"S Shmygalev","year":"2011","unstructured":"Shmygalev S, Damm M, Weckbecker K, Berghaus G, Petzke F, Sabatowski R. The impact of long-term maintenance treatment with buprenorphine on complex psychomotor and cognitive function. Drug Alcohol Depend. 2011;117(2\u20133):190\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.01.017. (Epub 2011 Feb 25 PMID: 21353749).","journal-title":"Drug Alcohol Depend"},{"key":"3084_CR71","unstructured":"Kapitzke D, Vetter I, Cabot PJ. Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control. Ther Clin Risk Manag. 2005;1(4):279\u201397. PMID: 18360571; PMCID: PMC1661636."},{"issue":"5","key":"3084_CR72","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1185\/03007995.2012.678938","volume":"28","author":"RF Wolff","year":"2012","unstructured":"Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R, Kleijnen J. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin. 2012;28(5):833\u201345. https:\/\/doi.org\/10.1185\/03007995.2012.678938. (Epub 2012 Apr 25 PMID: 22443154).","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"3084_CR73","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1507\/endocrj.ej11-0095","volume":"58","author":"C Aurilio","year":"2011","unstructured":"Aurilio C, Ceccarelli I, Pota V, Sansone P, Massafra C, Barbarisi M, Pace MC, Passavanti MB, Bravi F, Aloisi AM. Endocrine and behavioural effects of transdermal buprenorphine in pain-suffering women of different reproductive ages. Endocr J. 2011;58(12):1071\u20138. https:\/\/doi.org\/10.1507\/endocrj.ej11-0095. (Epub 2011 Sep 22 PMID: 21937837).","journal-title":"Endocr J"},{"issue":"10","key":"3084_CR74","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1074\/jbc.M604367200","volume":"282","author":"J Wang","year":"2007","unstructured":"Wang J, Barke RA, Roy S. Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine. J Biol Chem. 2007;282(10):7164\u201371. https:\/\/doi.org\/10.1074\/jbc.M604367200. (Epub 2007 Jan 16 PMID: 17227776).","journal-title":"J Biol Chem"},{"issue":"1","key":"3084_CR75","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","volume":"2","author":"P Sacerdote","year":"2008","unstructured":"Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008;2(1):14\u20138. https:\/\/doi.org\/10.1097\/SPC.0b013e3282f5272e. (PMID: 18685388).","journal-title":"Curr Opin Support Palliat Care"},{"issue":"6","key":"3084_CR76","doi-asserted-by":"publisher","first-page":"387","DOI":"10.7326\/0003-4819-150-6-200903170-00103","volume":"150","author":"MJ Krantz","year":"2009","unstructured":"Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Ann Intern Med. 2009;150(6):387\u201395. https:\/\/doi.org\/10.7326\/0003-4819-150-6-200903170-00103. (Epub 2009 Jan 19 PMID: 19153406).","journal-title":"Ann Intern Med"},{"issue":"6","key":"3084_CR77","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1360-0443.2009.02549.x","volume":"104","author":"K Anchersen","year":"2009","unstructured":"Anchersen K, Clausen T, Gossop M, Hansteen V, Waal H. Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study. Addiction. 2009;104(6):993\u20139. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02549.x. (Epub 2009 Apr 9 PMID: 19392907).","journal-title":"Addiction"},{"issue":"3","key":"3084_CR78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/10550880802122596","volume":"27","author":"P Athanasos","year":"2008","unstructured":"Athanasos P, Farquharson AL, Compton P, Psaltis P, Hay J. Electrocardiogram characteristics of methadone and buprenorphine maintained subjects. J Addict Dis. 2008;27(3):31\u20135. https:\/\/doi.org\/10.1080\/10550880802122596. (PMID: 18956527).","journal-title":"J Addict Dis"},{"issue":"22","key":"3084_CR79","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1001\/archinte.167.22.2469","volume":"167","author":"EF Wedam","year":"2007","unstructured":"Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med. 2007;167(22):2469\u201375. https:\/\/doi.org\/10.1001\/archinte.167.22.2469. (PMID: 18071169).","journal-title":"Arch Intern Med"},{"issue":"5","key":"3084_CR80","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.clinthera.2010.04.018","volume":"32","author":"A Gordon","year":"2010","unstructured":"Gordon A, Callaghan D, Spink D, Cloutier C, Dzongowski P, O\u2019Mahony W, Sinclair D, Rashiq S, Buckley N, Cohen G, Kim J, Boulanger A, Piraino PS, Eisenhoffer J, Harsanyi Z, Darke AC, Michalko KJ. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther. 2010;32(5):844\u201360. https:\/\/doi.org\/10.1016\/j.clinthera.2010.04.018. (PMID: 20685494).","journal-title":"Clin Ther"},{"issue":"4","key":"3084_CR81","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.arr.2010.06.001","volume":"9","author":"D Seripa","year":"2010","unstructured":"Seripa D, Pilotto A, Panza F, Matera MG, Pilotto A. Pharmacogenetics of cytochrome P450 (CYP) in the elderly. Ageing Res Rev. 2010;9(4):457\u201374. https:\/\/doi.org\/10.1016\/j.arr.2010.06.001. (Epub 2010 Jun 20 PMID: 20601196).","journal-title":"Ageing Res Rev"},{"issue":"Suppl 1","key":"3084_CR82","doi-asserted-by":"publisher","first-page":"s17","DOI":"10.1191\/0269216306pm1127oa","volume":"20","author":"RH B\u00f6ger","year":"2006","unstructured":"B\u00f6ger RH. Renal impairment: a challenge for opioid treatment? The role of buprenorphine Palliat Med. 2006;20(Suppl 1):s17-23 (PMID: 16764217).","journal-title":"The role of buprenorphine Palliat Med"},{"issue":"16","key":"3084_CR83","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/TCRM.S262843.PMID:32982255;PMCID:PMC7490082","volume":"9","author":"F Coluzzi","year":"2020","unstructured":"Coluzzi F, Caputi FF, Billeci D, Pastore AL, Candeletti S, Rocco M, Romualdi P. Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists. Ther Clin Risk Manag. 2020;9(16):821\u201337. https:\/\/doi.org\/10.2147\/TCRM.S262843.PMID:32982255;PMCID:PMC7490082.","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"3084_CR84","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.amjms.2022.06.025","volume":"364","author":"C Brandt","year":"2022","unstructured":"Brandt C, Atkinson TJ. A review of the safety of buprenorphine in special populations. Am J Med Sci. 2022;364(6):675\u201384. https:\/\/doi.org\/10.1016\/j.amjms.2022.06.025.","journal-title":"Am J Med Sci"},{"key":"3084_CR85","doi-asserted-by":"crossref","unstructured":"Filitz, J.; Grieinger, N.\u00df; Sittl, R.; Likar, R.; Sch\u00fcttler, J.; Koppert, W.. Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine: A-720. European Journal of Anaesthesiology. 2005;22():186.","DOI":"10.1097\/00003643-200505001-00671"},{"issue":"3","key":"3084_CR86","doi-asserted-by":"publisher","first-page":"37517","DOI":"10.52965\/001c.37517.PMID:35999975;PMCID:PMC9392838","volume":"10","author":"S Poliwoda","year":"2022","unstructured":"Poliwoda S, Noor N, Jenkins JS, Stark CW, Steib M, Hasoon J, Varrassi G, Urits I, Viswanath O, Kaye AM, Kaye AD. Buprenorphine and its formulations: a comprehensive review. Health Psychol Res. 2022;10(3):37517. https:\/\/doi.org\/10.52965\/001c.37517.PMID:35999975;PMCID:PMC9392838.","journal-title":"Health Psychol Res"},{"issue":"14","key":"3084_CR87","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2147\/JPR.S305146.PMID:34079354;PMCID:PMC8163969","volume":"24","author":"M Hale","year":"2021","unstructured":"Hale M, Garofoli M, Raffa RB. Benefit-Risk Analysis of Buprenorphine for Pain Management. J Pain Res. 2021;24(14):1359\u201369. https:\/\/doi.org\/10.2147\/JPR.S305146.PMID:34079354;PMCID:PMC8163969.","journal-title":"J Pain Res"},{"issue":"2","key":"3084_CR88","doi-asserted-by":"publisher","first-page":"98","DOI":"10.35366\/99012","volume":"44","author":"JJ Posso-Sierra","year":"2021","unstructured":"Posso-Sierra JJ, Carrillo-Torres O, Carrillo-Ruiz JD, et al. Therapeutic efficacy of buprenorphine for treatment of acute postoperative pain in thoracic surgery by thoracoscopy. Rev Mex Anest. 2021;44(2):98\u2013104. https:\/\/doi.org\/10.35366\/99012.","journal-title":"Rev Mex Anest"},{"key":"3084_CR89","doi-asserted-by":"publisher","unstructured":"Buresh M, Ratner J, Zgierska A, Gordin V, Alvanzo A. Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations. J Gen Intern Med. 2020;35(12):3635\u20133643. https:\/\/doi.org\/10.1007\/s11606-020-06115-3. Epub 2020 Aug 21. PMID: 32827109; PMCID: PMC7728902.","DOI":"10.1007\/s11606-020-06115-3"},{"key":"3084_CR90","doi-asserted-by":"publisher","unstructured":"Albaqami MS, Alqarni AA, Alabeesy MS, Alotaibi AN, Alharbi HA, Alshammari MM, Aldhfery AH. Buprenorphine for acute post-surgical pain: A systematic review and meta-analysis. Saudi J Anaesth. 2023;17(1):65\u201371. https:\/\/doi.org\/10.4103\/sja.sja_822_22. Epub 2023 Jan 2. PMID: 37032687; PMCID: PMC10077784.","DOI":"10.4103\/sja.sja_822_22"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03084-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T11:37:19Z","timestamp":1745667439000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-025-03084-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3084"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03084-0","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"216"}}